Search

Search Constraints

You searched for: Author/Creator Schmidt, Henrik

Search Results

1. A case report: metastasis of melanoma to the heart in an era of immunotherapy. Issue 4 (26th October 2019)

3. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Issue 5 (May 2015)

4. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

5. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

6. Association between inflammatory markers and survival in comatose, resuscitated out-of-hospital cardiac arrest patients. (31st December 2022)